• This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Sun - Fri 8:00 - 20:30
'Press Releases' Section describes most distant clients with latest product-specific, company-related updates is a key value addition to our members because they can use this platform as the easiest, earlier and the most effective means to get noticed quickly. Our press release programs work hand in hand with our SEO programs to provide a rock solid positioning in all major search engines so as to contemplate the visibility of your message for Worldwide Healthcare industry.

To learn more on how to reach a suitable target audience by distributing / publicizing your content(the latest happenings about your company) as in 'Press Releases' through 'Global Healthcare Technology', This email address is being protected from spambots. You need JavaScript enabled to view it.
Onera STS hPSG system

A landmark study validates Onera's patch-based home polysomnography system in one of the decade's largest sleep diagnostic trials

Onera Health, a leader in transforming sleep medicine and remote monitoring, announced the publication of a multicenter validation study of its Onera Sleep Test System (STS) in the Journal of Clinical Sleep Medicine, the official journal of the American Academy of Sleep Medicine. The study demonstrated that the patch-based Onera STS home-polysomnography (hPSG) performs comparably to gold-standard in-lab polysomnography (PSG) for both sleep staging and respiratory event detection.

Read more →
Lunit

Lunit and Volpara debut a unified ecosystem at aiming to revolutionize global cancer care through integrated technology

Lunit a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, and Volpara Health, a Lunit company and a global leader in mammography AI  for the early detection of cancer, announced their unified vision, focusing on a comprehensive Ecosystem for early cancer detection, cancer risk prediction, and autonomous AI for enhanced clinical workflows.

Read more →
Physicians Choice

Nsight Health partners with Physicians Choice® Medical to deliver advanced patient monitoring solutions, enhancing provider capabilities

Nsight Health, a leader in Remote Patient Monitoring (RPM) and Chronic Care Management (CCM), has announced an exciting new partnership with Physicians Choice® Medical, a trusted provider of Billing, Revenue Cycle Management, Credentialing, and Practice Management consulting.

Read more →
Hyperfine

Hyperfine's Swoop® Portable MR System achieves compliance with new standards from a CMS-approved accrediting body

Hyperfine, Inc. the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—announced the issuance of new MRI standards by the Intersocietal Accreditation Commission (IAC), a leading CMS-approved accrediting body. The new standards, effective immediately, now include portable MR scanning at the point of care.

Read more →
OMRON blood pressure monitors

FDA Grants De Novo Authorization to OMRON Healthcare for New Blood Pressure Monitors with AI-Powered AFib Detection Feature

In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare announced the U.S. Food and Drug Administration (FDA) has granted the company its De Novo authorization to market new home blood pressure monitors featuring breakthrough AI-powered atrial fibrillation detection. In a medical device first, OMRON's novel machine learning IntelliSense™ AFib algorithm automatically analyzes the Pressure Pulse Wave generated during blood pressure measurement to detect AFib, a leading cause of stroke1.

Read more →
Shockwave Javelin Peripheral IVL Catheter

Shockwave Medical reveals initial clinical outcomes for its new IVL platform

Shockwave Medical, Inc., part of Johnson & Johnson MedTech and a global leader in the field of circulatory restoration, announced the first clinical outcomes associated with the Shockwave Javelin Peripheral IVL Catheter, a novel, non-balloon-based lithotripsy platform designed to modify calcium and cross extremely narrowed vessels in patients with peripheral artery disease (PAD).

Read more →